Acurx Pharmaceuticals ACXP
NASDAQ ACXP
$1.15 +0.01 (+0.88%)
As of: Oct 21, 2026 · 1:19 PM EDT

Acurx Pharmaceuticals (ACXP) EBT (2024 - 2026)

Updated

Acurx Pharmaceuticals' EBT came in at -$2.25 million for Q2 2026, compared with -$2.25 million a year earlier.

Analysis

Acurx Pharmaceuticals (ACXP) EBT (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Acurx Pharmaceuticals reported EBT of -$7.51 million; for FY2025, it was -$7.97 million.

  • Going back by year, EBT was -$14.1 million in FY2024.
  • The Q2 2026 figure represents the lowest quarterly EBT since Q4 2024.
  • Business Quant data shows ACXP's EBT at -$1.68 million (Q1 2026), -$1.58 million (Q4 2025) and -$1.99 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Eli Lilly 1,134.50 Bn 1,103.09 Bn 19.71 Bn 9.25 Bn
2 Johnson & Johnson 616.20 Bn 534.73 Bn 17.26 Bn 6.75 Bn
3 AbbVie 500.82 Bn 473.93 Bn 12.70 Bn 4.28 Bn
4 Merck 367.31 Bn 321.69 Bn 12.21 Bn -683.00 Mn
5 Novartis Ag 297.77 Bn 261.76 Bn 11.24 Bn 4.27 Bn
6 Astrazeneca 261.35 Bn 235.04 Bn 12.86 Bn 2.80 Bn
7 Amgen 235.40 Bn 190.80 Bn 7.24 Bn 2.77 Bn
8 Gilead Sciences 190.59 Bn 164.79 Bn 6.22 Bn -10.25 Bn
9 Pfizer 169.39 Bn 116.04 Bn 10.94 Bn -653.00 Mn
10 Acurx Pharmaceuticals 4.90 Mn -28.56 Mn - -2.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.25 Mn
Mar 31, 2026 -1.68 Mn
Dec 31, 2025 -1.58 Mn
Sep 30, 2025 -1.99 Mn
Jun 30, 2025 -2.25 Mn
Mar 31, 2025 -2.15 Mn
Dec 31, 2024 -2.78 Mn
Sep 30, 2024 -2.82 Mn
Jun 30, 2024 -4.12 Mn
API Access

Acurx Pharmaceuticals EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=ACXP&period=max&api_key=YOUR_API_KEY